ARTICLE | Company News
Chelsea falls on FDA Northera advice
July 4, 2012 1:04 AM UTC
Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) fell $0.60 (41%) to $0.87 on Tuesday after it said FDA recommended the company conduct an additional trial of Northera droxidopa to support an NDA...